Portal de Periódicos da CAPES

Melanoma and sun exposure: where are we now?

1999; Wiley; Volume: 38; Issue: 7 Linguagem: Inglês

10.1046/j.1365-4362.1999.00712.x

1365-4632

David C. Whiteman, Mbbs, Adèle C. Green, Mbbs,

Cutaneous lymphoproliferative disorders research

International Journal of DermatologyVolume 38, Issue 7 p. 481-489 Melanoma and sun exposure: where are we now? David C. Whiteman, David C. Whiteman The ICRF General Practice Research Group, Institute of Health Sciences, University of Oxford, UK, and Epidemiology and Population Health Unit, Queensland Institute of Medical Research, Queensland, AustraliaSearch for more papers by this author. MBBS PhD, . MBBS PhD The ICRF General Practice Research Group, Institute of Health Sciences, University of Oxford, UK, and Epidemiology and Population Health Unit, Queensland Institute of Medical Research, Queensland, AustraliaSearch for more papers by this authorAdele C. Green, Adele C. Green The ICRF General Practice Research Group, Institute of Health Sciences, University of Oxford, UK, and Epidemiology and Population Health Unit, Queensland Institute of Medical Research, Queensland, AustraliaSearch for more papers by this author. MBBS PhD, . MBBS PhD The ICRF General Practice Research Group, Institute of Health Sciences, University of Oxford, UK, and Epidemiology and Population Health Unit, Queensland Institute of Medical Research, Queensland, AustraliaSearch for more papers by this author David C. Whiteman, David C. Whiteman The ICRF General Practice Research Group, Institute of Health Sciences, University of Oxford, UK, and Epidemiology and Population Health Unit, Queensland Institute of Medical Research, Queensland, AustraliaSearch for more papers by this author. MBBS PhD, . MBBS PhD The ICRF General Practice Research Group, Institute of Health Sciences, University of Oxford, UK, and Epidemiology and Population Health Unit, Queensland Institute of Medical Research, Queensland, AustraliaSearch for more papers by this authorAdele C. Green, Adele C. Green The ICRF General Practice Research Group, Institute of Health Sciences, University of Oxford, UK, and Epidemiology and Population Health Unit, Queensland Institute of Medical Research, Queensland, AustraliaSearch for more papers by this author. MBBS PhD, . MBBS PhD The ICRF General Practice Research Group, Institute of Health Sciences, University of Oxford, UK, and Epidemiology and Population Health Unit, Queensland Institute of Medical Research, Queensland, AustraliaSearch for more papers by this author First published: 25 December 2001 https://doi.org/10.1046/j.1365-4362.1999.00712.xCitations: 38 David C. Whiteman, mbbs, ph d, ICRF General Practice Research Group, Institute of Health Sciences, University of Oxford, Old Road, Headington OX3 7LF, UK Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 McGovern, VJ. Melanoblastoma. Med J Aust 1952; i, 139 142. 2 International Agency for Research on Cancer. .Solar and ultraviolet radiation. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 55. Lyon. International Agency for Research on Cancer, 1992. 3 Parkin, DM, Muir, CS, Whelan, SL et al. eds. Cancer incidence in five continents. IARC Scientific Publications No. 120, Vol. 6. Lyon: International Agency for Research on Cancer, 1992. 4 Lancaster, HO. Some geographical aspects of the mortality from melanoma in Europeans. Med J Aust 1956; i, 1082 1087. 5 Swerdlow, AJ. Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine. Br Med J 1979; 2, 1324 1327. 6 Magnus, K. Incidence of malignant melanoma of the skin in Norway. 1955–70: variations in time and space and solar radiation. Cancer 1973; 32, 1275 1286. 7 Eklund, G & Malec, E. Sunlight and incidence of cutaneous malignant melanoma. Scand J Plas Reconstr Surg 1978; 12, 231 241. 8 Teppo, L, Pakkanen, M, Hakulinsen, T. Sunlight as a risk factor of malignant melanoma of the skin. Cancer 1978; 41, 2018 2027. 9 Bulliard, JL, Cox, B, Elwood, JM. Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand. Cancer Causes Control 1994 5, 234 240. 10 Crombie, IK. Variation of melanoma incidence with latitude in North America and Europe. Br J Cancer 1979; 40, 774 781. 11 Fears, TR, Scotto, J, Schneiderman, MA. Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. Am J Epidemiol 1977; 105, 420 427. 12 Osterlind, A & Moller-Jensen, O. Trends in incidence of malignant melanoma of the skin in. Denmark 194382 Recent Results Cancer Res 1986; 102, 8 17. 13 Magnus, K. Habits of sun exposure and risk of malignant melanoma: an analysis of incidence rates In Norway 195577 by cohort, sex, age and primary tumor site. Cancer 1981; 48, 2329 2335. 14 Green, A, MacLennan, R, Youl, P, Martin, N. Site distribution of cutaneous melanoma in Queensland. Int J Cancer 1993; 53, 232 236. 15 Popescu, NA, Beard, CM, Treacy, PJ et al. Cutaneous malignant melanoma in Rochester., Minnesota: Trends in Incidence and Survivorship, 1950 through 1985. Mayo Clinic Proc1990; 65, 1293 1302. 16 Masback, A, Westerdahl, J, Ingvar, C et al. Cutaneous Malignant Melanoma in South Sweden, 1965, 1975, and 1985. A histopathologic review. Cancer 1994 ; 73, 1625 1630. 17 Chen, YT, Zheng, T, Holford, TR et al. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site. Cancer Causes Control 1994; 5, 341 350. 18 Osterlind, A, Hou-Jensen, K, Moller-Jensen, O. Incidence of cutaneous malignant melanoma in Denmark 197882 Anatomic site distribution, histologic types and comparison with non-melanoma skin Cancer. Br J Cancer 1981; 58, 385 391. 19 Beral, V & Robinson, N. The relationship of malignant melanoma, basal and squamous skin cancers to indoor and outdoor work. Br J Cancer 1981; 44, 886 891. 20 Coleman, MP, Esteve, J, Damiecki, P et al. eds. Trends in Cancer Incidence and Mortality, Vol. 121. Lyon: International Agency for Research on Cancer, 1993. 21 Giles, GG, Armstrong, BK, Burton, RC et al. Has mortality from melanoma stopped rising in Australia? Analysis of trends between. 1931 and 1994 Br Med J 1931 312, 1121 1125. 22 Stevens, RG & Moolgavkar, SH. Malignant melanoma: dependence of site specific risk on age. Am J Epidemiol 1984; 119, 890 895. 23 Thorn, M, Bergstrom, R, Adami, H-O, Ringborg, U. Trends in the incidence of malignant melanoma in Sweden, by anatomic site. 1960–84. Am J Epidemiol 1990; 132, 1066 1077. 24 Dennis, LK, White, E, Lee, JA. Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Causes Control 1993; 4, 93 100. 25 McCredie, M, Coates, MS, Ford, JM. Cancer incidence in migrants to New South Wales from England, Wales, Scotland and Ireland. Br J Cancer 1990; 62, 992 995. 26 Steinitz, R, Parkin, DM, Young, JL et al. Cancer incidence in Jewish migrants to Israel. 1961–81. IARC Scientific Publications No. 98. Lyon: International Agency for Research on Cancer, 1989. 27 Cooke, KR & Fraser, J. Migration and death from malignant melanoma. Int J Cancer 1985; 36, 175 178. 28 Holman, CD & Armstrong, BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984; 73, 75 82. 29 Khlat, M, Vail, A, Parkin, M, Green, A. Mortality from melanoma in immigrants to Australia: variations by age on arrival and duration of stay. Am J Epidemiol 1992; 135, 1103 1113. 30 Mack, TM & Floderus, B. Malignant melanoma risk by nativity, place of residence at diagnosis, and age at migration. Cancer Causes Control 1991; 2, 401 411. 31 Autier, P, Dore, JF, Gefeller, O et al. Melanoma risk and residence in sunny areas. EORTC Melanoma Co-operative Group. European Organization for Research and Treatment of Cancer. Br J Cancer 1997; 76, 1521 1524. 32 Swerdlow, AJ, Marmot, MG, Grulich, AE, Head, J. Cancer mortality in Indian and British ethnic immigrants from the Indian subcontinent to England and Wales. Br J Cancer 1995; 72, 1312 1319. 33 Swerdlow, A, Cooke, KR, Skegg, DCG, Wilkinson, J. Cancer incidence in England and Wales and New Zealand and in migrants between the two countries. Br J Cancer 1995; 72, 236 243. 34 Elwood, JM. Recent developments in melanoma epidemiology. 1993; Melanoma Res 1993; 3, 149 156. 35 Finkel, E. Sorting the hype from the facts in melanoma. Lancet 1998; 351, 1866. 36 Bliss, JM, Ford, D, Swerdlow, AJ et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. Int J Cancer 1995; 62, 367 376. 37 Green, A, MacLennan, R, Siskind, V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer 1985; 35, 297 300. 38 Holly, EA, Kelly, JW, Shpall, SN, Chiu, SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17, 459 468. 39 Elwood, JM, Whitehead, SM, Davison, J et al. Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. Int J Epidemiol 1990; 19, 801 810. 40 Ford, D, Bliss, JM, Swerdlow, AJ et al. Risk of cutaneous melanoma associated with a family history of the disease. Int J Cancer 1995; 62, 377 381. 41 Elwood, JM, Gallagher, RP, Hill, GB, Pearson, JC. Cutaneous melanoma in relation to intermittent and constant sun exposure—The Western Canada Melanoma Study. Int J Cancer 1985; 35, 427 433. 42 Armstrong, BK. Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun. J Dermatol Surg Oncol 1988; 14, 835 849. 43 Osterlind, A, Tucker, MA, Hou-Jensen, K et al. The Danish case-control study of cutaneous malignant melanoma I. Importance of host factors. Int J Cancer 1988; 42, 200 206. 44 Nelemans, PJ, Rampen, FHJ, Ruiter, DJ, Verbeek, ALM. An addition to the controversy on sunlight exposure and melanoma risk: a meta-analytical approach. J Clin Epidemiol 1995; 48, 1331 1342. 45 Elwood, JM & Jopson, J. Melanoma and sun exposure. an overview of published studies, Int J Cancer . ; 73 :198 203., 1997. 46 Elwood, JM & Diffey, BL. A consideration of ambient solar ultraviolet radiation in the interpretation of studies of the aetiology of melanoma. Melanoma Res 1993; 3, 113 122. 47 Green, A. Sun exposure and the risk of melanoma. Aust J Derm 1984; 25, 99 102. 48 Holman, CD, Armstrong, BK, Heenan, PJ. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986; 76, 403 414. 49 Osterlind, A, Tucker, MA, Stone, BJ, Jensen, OM. The Danish case-control study of cutaneous malignant melanoma II. Importance of UV-light exposure. Int J Cancer 1988; 42, 319 324. 50 Whiteman, D & Green, A. Melanoma and sunburn. Cancer Causes Control 1994; 5, 564 572. 51 Elwood, JM, Gallagher, RP, Davison, J, Hill, GB. Sunburn. suntan and the risk of cutaneous malignant melanoma—The Western Canada Melanoma Study. Br J Cancer 1985; 51, 543 549. 52 Green, A, Siskind, V, Bain, C, Alexander, J. Sunburn and malignant melanoma. Br J Cancer 1985; 51, 393 397. 53 Zanetti, R, Franceschi, S, Rosso, S et al. Cutaneous melanoma and sunburns in childhood in a southern European population. Eur J Cancer 1992; 28, 1172 1176. 54 Kraemer, KH, Lee, MM, Andrews, AD, Lambert, WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 1994; 130, 1018 1021. 55 Levi, F, Randimbison, L, La-Vecchia, C et al. Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol 1997; 146, 734 739. 56 Frisch, M & Melbye, M. New primary cancers after squamous cell skin cancer. Am J Epidemiol 1995; 141, 916 922. 57 Levi, F, La-Vecchia, C, Randimbison, L et al. Incidence of invasive cancers following cutaneous malignant melanoma. Int J Cancer 1997; 72, 776 779. 58 Naylor, MF & Farmer, KC. The case for sunscreens. A review of their use in preventing actinic damage and neoplasia. Arch Dermatol 1997; 133, 1146 1154. 59 Green, AC & O'Rourke, MGE. Cutaneous malignant melanoma in association with other skin cancers. J Natl Cancer Inst 1985; 74, 977 980. 60 Bataille, V, Sasieni, P, Grulich, A et al. Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi. Int J Cancer 1998; 78, 8 12. 61 Whiteman, DC, Green, A, Parson, PG. p53 Expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer 1998; 77, 843 848. 62 Lane, DP. p53, guardian of the genome. Nature 1992; 359, 486 487. 63 Kamb, A, Gruis, NA, Weaver-Feldhaus, J et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264, 436 450. 64 Liu, Q, Neuhasen, S, McClure, M et al. CDKN2 (MTS1) tumour suppressor gene mutations in human tumour cell lines. Oncogene 1995; 10, 1061 1067. 65 Pollock, PM, Yu, F, Qui, L et al. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines. Oncogene 1995; 11, 663 668. 66 Maestro, R & Boiocchi, M. Sunlight and melanoma: an answer from MTS1 p16. Science 1994; 267, 15 16. 67 Herbst, RA, Gutzmer, R, Matiaske, F et al. Further evidence for ultraviolet light induction of CDKN2 (p16INK4) mutations in sporadic melanoma in vivo [letter; comment]. J Invest Dermatol 1997; 108, 950. 68 Brash, D, Rudolph, JA, Simon, JA et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88, 10124 10128. 69 Ziegler, A, Leffell, DJ, Kunala, S et al. Mutation hotspots due to sunlight in the p53 gene of non-melanoma skin cancers. Proc Natl Acad Sci USA 1993; 90, 4216 4220. 70 Ziegler, A, Jonason, AS, Leffell, DJ et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372, 773 776. 71 Nakazawa, H, English, D, Randell, P et al. UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci USA 1994; 91, 360 364. 72 Stretch, JR, Gatter, KC, Ralfkiaer, E et al. Expression of mutant p53 in melanoma. Cancer Res 1991; 51, 5976 5979. 73 Lassam, NJ, From, L, Kahn, HJ. Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res 1993; 53, 2235 2238. 74 Cristofolini, M, Boi, S, Girlando, S et al. p53 protein expression in nevi and melanomas. Arch Dermatol 1993; 129, 739 743. 75 Platz, A, Ringborg, U, Grafstrom, E et al. Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma. Melanoma Res 1995; 5, 101 106. 76 Sparrow, LE, Soong, R, Dawkins, HJS et al. p53 gene mutation and expression in naevi and melanomas. Melanoma Res 1995; 5, 93 100. 77 McGregor, J, Yu, C, Dublin, E et al. p53 immunoreactivity in human malignant melanoma and dysplastic naevi. Br J Dermatol 1993; 128, 606 611. 78 Castresana, JS, Rubio, MP, Vazquez, JJ et al. Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int J Cancer 1993; 554, 562 565. 79 Albino, AB, Vidal, MJ, McNutt, NS et al. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res 1994; 4, 35 45. 80 Hall, PA & Lane, DP. p53 in the tumour pathology: can we trust immunohistochemistry?—revisited!. J Pathol 1994; 172, 1 4. 81 Poremba, C, Yandell, DW, Metze, D et al. Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression. Oncol Res 1995; 7, 331 339. 82 Straume, O & Akslen, LA. Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. Int J Cancer 1997; 74, 535 539. 83 Van't-Veer, LJ, Burgering, BM, Versteeg, R et al. N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell Biol 1989; 9, 3114 3116. 84 Van-Elsas, A, Zerp, SF, Van-der-Flier, S et al. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma [see comments]. Am J Pathol 1996; 149, 883 893. 85 Mooy, CM, Van-der-Helm, MJ, Van-der-Kwast, TH et al. No N-ras mutations in human uveal melanoma: the role of ultraviolet light revisited. Br J Cancer 1991; 64, 411 413. 86 Green, A, Neale, R, Kelly, R et al. An animal model for human melanoma. Photochem Photobiol 1996; 64, 577 580. 87 Setlow, RB, Woodhead, AD, Grist, E. Animal model for ultraviolet-radiation induced melanoma: platyfish–swordtail hybrid. Proc Natl Acad Sci USA 1989; 86, 8922 8926. 88 Atillasoy, ES, Seykora, JT, Soballe, PW et al. UVB induces atypical melanocytic lesions and melanoma in human skin. Am J Pathol 1998; 152, 1179 1186. 89 Staples, M, Marks, R, Giles, G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 198595 are primary prevention programs starting to have an effect? Int J Cancer 1998; 78, 144 148. 90 De-Gruijl, FR. Action spectrum for photocarcinogenesis. Recent Results Cancer Res 1995; 139, 21 30. 91 Gasparro, FP, Mitchnik, M, Nash, JF. A review of sunscreen safety and efficacy. Photochem Photobiol 1998; 68, 243 256. 92 Ananthaswamy, HN, Loughlin, SM, Cox, P et al. Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens. Nat Med 1997; 3, 510 514. 93 Wolf, P, Donawho, CK, Kripke, ML. Analysis of the protective effect of different sunscreens on ultraviolet radiation-induced local and systemic suppression of contact hypersensitivity and inflammatory responses in mice. J Invest Dermatol 1993; 100, 254 259. 94 Bestak, R & Halliday, GM. Sunscreens protect from UV-promoted squamous cell carcinoma in mice chronically irradiated with doses of UV radiation insufficient to cause edema. Photochem Photobiol 1996; 64, 188 193. 95 Donawho, C & Wolf, P. Sunburn. sunscreen, and melanoma. Curr Opin Oncol 1996; 8, 159 166. 96 Autier, P, Dore, JF, Schifflers, E et al. Melanoma and use of sunscreens: an EORTC case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group. Int J Cancer 1995; 61, 749 755. 97 Autier, P, Dore, JF, Renard, F et al. Melanoma and sunscreen use: need for studies representative of actual behaviours. Melanoma Res 1997; 7 (Suppl. 2), S115 S120. 98 MacKie, RM & Hole, D. Audit of public education campaign to encourage earlier detection of malignant melanoma. Br Med J 1992; 304, 1012 1015. 99 Berwick, M, Begg, CB, Fine, JA et al. Screening for Cutaneous Melanoma by Skin Self-Examination [See Comments]. J Natl Cancer Inst 1996; 88, 17 23. Citing Literature Volume38, Issue7July 1999Pages 481-489 ReferencesRelatedInformation